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1107 Genetic control of postoperative systemic inflammatory reaction and
pulmonary and renal complications after coronary artery surgery
Mario Gaudino, MD, Augusto Di Castelnuovo, MS, Roberto Zamparelli, MD,
Felicita Andreotti, MD, Francesco Burzotta, MD, Licia Iacoviello, MD, PhD, Franco Glieca,
MD, Francesco Alessandrini, MD, Giuseppe Nasso, MD, Maria Benedetta Donati, MD, Attilio
Maseri, MD, Rocco Schiavello, MD, and Gianfederico Possati, MD, Rome and Santa Maria
Imbaro, Italy
In a series of 111 consecutive patients having primary isolated CABG, the IL-6 174 G/C
polymorphism was found to modulate postoperative IL-6 levels and the degree of postoperative
renal and pulmonary dysfunction as well as in-hospital stay.
1113 Gelatin sheet incorporating basic fibroblast growth factor enhances sternal
healing after harvesting bilateral internal thoracic arteries
Atsushi Iwakura, MD, Yasuhiko Tabata, PhD, Tadaaki Koyama, MD, Kazuhiko Doi, MD,
Kazunobu Nishimura, MD, Kazuaki Kataoka, MD, Masatoshi Fujita, MD, and
Masashi Komeda, MD, Kyoto, Japan
A gelatin sheet incorporating bFGF enhances sternal perfusion and accelerates sternal bone
healing after a median sternotomy with bilateral ITA harvesting.
General Thoracic
Surgery
(GTS)
1121 Extracapsular lymph node involvement is a negative prognostic factor in T3
adenocarcinoma of the distal esophagus and gastroesophageal junction
T. Lerut, MD, PhD, W. Coosemans, MD, PhD, G. Decker, MD, P. De Leyn, MD, PhD,
N. Ectors, MD, PhD, S. Fieuws, Msc, J. Moons, CNS, P. Nafteux, MD, and
D. Van Raemdonck, MD, PhD, for the Leuven Collaborative Workgroup for Esophageal
Carcinoma, Leuven, Belgium
The mode of lymph node involvement (ie, intracapsular versus extracapsular breakthrough) was
studied in 195 consecutive patients with pT3 adenocarcinoma of the distal esophagus and
gastroesophageal junction. Extracapsular lymph node involvement proved to be an independent
negative prognostic factor. Intracapsular lymph node involvement had similar survival as N0
patients.
1129 Cyclooxygenase-2 inhibition decreases primary and metastatic tumor burden
in a murine model of orthotopic lung adenocarcinoma
Costanzo A. DiPerna, MD, Robert D. Bart, MD, Eric M. Sievers, MD, Yanling Ma, MD,
Vaughn A. Starnes, MD, and Ross M. Bremner, MD, PhD, Los Angeles, Calif
Using a cell line derived from human female lung adenocarcinoma-expressing COX-2
implanted in SCID mice, the effect of a COX-2 inhibitor, celecoxib, was evaluated. COX-2
inhibition significantly reduced primary tumor volume and mediastinal metastatic disease.
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